Logo image of FRTA

FORTERRA INC (FRTA) Stock Fundamental Analysis

NASDAQ:FRTA - Nasdaq - Common Stock

24  +0.93 (+4.03%)

After market: 23.99 -0.01 (-0.04%)

Fundamental Rating

2

Overall FRTA gets a fundamental rating of 2 out of 10. We evaluated FRTA against 11 industry peers in the Construction Materials industry. Both the profitability and financial health of FRTA have multiple concerns. FRTA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

FRTA had positive earnings in the past year.
FRTA Yearly Net Income VS EBIT VS OCF VS FCFFRTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M

1.2 Ratios

Industry RankSector Rank
ROA 6.56%
ROE 36.46%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FRTA Yearly ROA, ROE, ROICFRTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -50 -100 -150

1.3 Margins

Industry RankSector Rank
OM 11.69%
PM (TTM) 6.26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FRTA Yearly Profit, Operating, Gross MarginsFRTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, FRTA has more shares outstanding
The debt/assets ratio for FRTA has been reduced compared to a year ago.
FRTA Yearly Shares OutstandingFRTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M
FRTA Yearly Total Debt VS Total AssetsFRTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.39 indicates that FRTA is not a great score, but indicates only limited risk for bankruptcy at the moment.
FRTA has a Debt/Equity ratio of 3.20. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 3.2
Debt/FCF N/A
Altman-Z 2.39
ROIC/WACCN/A
WACCN/A
FRTA Yearly LT Debt VS Equity VS FCFFRTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.15 indicates that FRTA has no problem at all paying its short term obligations.
FRTA has a Quick Ratio of 1.25. This is a normal value and indicates that FRTA is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.25
FRTA Yearly Current Assets VS Current LiabilitesFRTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

FRTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.57%, which is quite impressive.
The Revenue has grown by 16.53% in the past year. This is quite good.
Measured over the past years, FRTA shows a small growth in Revenue. The Revenue has been growing by 6.38% on average per year.
EPS 1Y (TTM)79.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.12%
Revenue 1Y (TTM)16.53%
Revenue growth 3Y7.89%
Revenue growth 5Y6.38%
Sales Q2Q%23.91%

3.2 Future

The Earnings Per Share is expected to grow by 16.63% on average over the next years. This is quite good.
FRTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.94% yearly.
EPS Next Y17.88%
EPS Next 2Y15.65%
EPS Next 3Y15.92%
EPS Next 5Y16.63%
Revenue Next Year2.44%
Revenue Next 2Y2.45%
Revenue Next 3Y1.77%
Revenue Next 5Y1.94%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
FRTA Yearly Revenue VS EstimatesFRTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
FRTA Yearly EPS VS EstimatesFRTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2 3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.37, FRTA is valued correctly.
FRTA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.62.
With a Price/Forward Earnings ratio of 12.19, FRTA is valued correctly.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, FRTA is valued a bit cheaper.
Industry RankSector Rank
PE 14.37
Fwd PE 12.19
FRTA Price Earnings VS Forward Price EarningsFRTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.69
FRTA Per share dataFRTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FRTA's earnings are expected to grow with 15.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.8
PEG (5Y)N/A
EPS Next 2Y15.65%
EPS Next 3Y15.92%

More info and screens

0

5. Dividend

5.1 Amount

FRTA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORTERRA INC

NASDAQ:FRTA (3/17/2022, 8:00:00 PM)

After market: 23.99 -0.01 (-0.04%)

24

+0.93 (+4.03%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)N/A N/A
Earnings (Next)04-26 2022-04-26
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.72%
Ins Owner Change0%
Market Cap1.61B
Analysts80
Price Target24.48 (2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.37
Fwd PE 12.19
P/S 0.86
P/FCF N/A
P/OCF N/A
P/B 5.04
P/tB N/A
EV/EBITDA 8.69
EPS(TTM)1.67
EY6.96%
EPS(NY)1.97
Fwd EY8.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.75
BVpS4.76
TBVpSN/A
PEG (NY)0.8
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.56%
ROE 36.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 11.69%
PM (TTM) 6.26%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 3.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 1.25
Altman-Z 2.39
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.12%
EPS Next Y17.88%
EPS Next 2Y15.65%
EPS Next 3Y15.92%
EPS Next 5Y16.63%
Revenue 1Y (TTM)16.53%
Revenue growth 3Y7.89%
Revenue growth 5Y6.38%
Sales Q2Q%23.91%
Revenue Next Year2.44%
Revenue Next 2Y2.45%
Revenue Next 3Y1.77%
Revenue Next 5Y1.94%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A